DBV Technologies Correlations

DBVT Stock

USD 21.26 0.20 0.93%

The current 90-days correlation between DBV Technologies and Annexon is 0.13 (i.e., Average diversification). The correlation of DBV Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

DBV Technologies Correlation With Market

Poor diversification

The correlation between DBV Technologies and DJI is 0.71 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DBV Technologies and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with DBV Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.

Moving together with DBV Stock

0.69	DSGN	Design Therapeutics	Pair Corr
0.75	ENGN	enGene Holdings Common	Pair Corr
0.82	IMMP	Immutep Ltd ADR	Pair Corr
0.69	MRKR	Marker Therapeutics	Pair Corr
0.67	AVE	Avecho Biotechnology	Pair Corr
0.82	ANNX	Annexon	Pair Corr
0.81	SLDB	Solid Biosciences LLC	Pair Corr
0.73	BOLT	Bolt Biotherapeutics	Pair Corr
0.8	CADL	Candel Therapeutics	Pair Corr

Moving against DBV Stock

0.83	ABP	Abpro Holdings	Pair Corr
0.83	IMRN	Immuron Ltd ADR	Pair Corr
0.74	KURA	Kura Oncology	Pair Corr
0.71	GNLX	Genelux Common	Pair Corr
0.65	LYRA	Lyra Therapeutics	Pair Corr
0.63	DWTX	Dogwood Therapeutics	Pair Corr
0.63	EVGN	Evogene	Pair Corr
0.61	EDIT	Editas Medicine	Pair Corr
0.58	QSI	QuantumSi	Pair Corr
0.75	MBIO	Mustang Bio	Pair Corr
0.7	ACXP	Acurx Pharmaceuticals LLC	Pair Corr
0.59	PRQR	ProQR Therapeutics	Pair Corr
0.53	MREO	Mereo BioPharma Group	Pair Corr
0.47	PROK	ProKidney Corp	Pair Corr
0.32	GSD	Devonian Health Group Split	Pair Corr

Related Correlations Analysis

	LRMR	ANNX	ALT	KRRO	ENGN	AMRN	ANRO	LXEO	CLLS	LBRX
LRMR		-0.04	0.14	-0.03	0.08	-0.33	0.18	0.56	0.43	0.17	LRMR
ANNX	-0.04		0.37	-0.43	0.78	-0.3	0.64	-0.41	0.18	0.83	ANNX
ALT	0.14	0.37		-0.28	0.37	0.2	-0.11	-0.28	0.16	0.26	ALT
KRRO	-0.03	-0.43	-0.28		-0.3	0.15	-0.43	-0.23	-0.72	-0.37	KRRO
ENGN	0.08	0.78	0.37	-0.3		-0.2	0.54	-0.32	0.13	0.73	ENGN
AMRN	-0.33	-0.3	0.2	0.15	-0.2		-0.58	-0.28	-0.14	-0.54	AMRN
ANRO	0.18	0.64	-0.11	-0.43	0.54	-0.58		0.18	0.31	0.66	ANRO
LXEO	0.56	-0.41	-0.28	-0.23	-0.32	-0.28	0.18		0.59	-0.18	LXEO
CLLS	0.43	0.18	0.16	-0.72	0.13	-0.14	0.31	0.59		0.19	CLLS
LBRX	0.17	0.83	0.26	-0.37	0.73	-0.54	0.66	-0.18	0.19		LBRX
	LRMR	ANNX	ALT	KRRO	ENGN	AMRN	ANRO	LXEO	CLLS	LBRX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LBRX	+ 0.83	ANNX
ENGN	+ 0.78	ANNX
LBRX	+ 0.73	ENGN
LBRX	+ 0.66	ANRO
ANRO	+ 0.64	ANNX
CLLS	+ 0.59	LXEO

High negative correlations

CLLS	- 0.72	KRRO
ANRO	- 0.58	AMRN
LBRX	- 0.54	AMRN
ANRO	- 0.43	KRRO
KRRO	- 0.43	ANNX
LXEO	- 0.41	ANNX

Risk-Adjusted Indicators

There is a big difference between DBV Stock performing well and DBV Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DBV Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LRMR	3.57	(0.15)	0.00	(0.22)	0.00	0.00	7.76	(7.49)	20.14
ANNX	4.09	1.02	0.25	4.46	3.36	(5.21)	11.30	(6.79)	35.10
ALT	4.08	0.44	0.07	0.74	5.22	(5.13)	9.80	(6.22)	33.75
KRRO	5.08	(0.73)	0.00	(0.06)	0.00	0.00	10.98	(6.55)	83.21
ENGN	4.56	0.60	0.15	0.29	4.30	(5.66)	11.36	(7.21)	61.40
AMRN	2.31	(0.10)	0.00	(0.06)	0.00	0.00	4.89	(3.95)	21.26
ANRO	4.02	0.39	0.06	0.39	5.70	(3.89)	7.87	(8.77)	30.37
LXEO	3.47	(0.35)	0.00	(0.16)	0.00	0.00	7.04	(7.63)	34.26
CLLS	3.71	0.20	0.04	0.43	4.50	(4.21)	9.24	(7.69)	29.31
LBRX	4.03	0.78	0.16	(0.81)	3.58	(4.96)	10.43	(6.59)	23.59

DBV Technologies Corporate Management

Jonathan Neely	VP Relations	Profile
PharmD D	Chief Officer	Profile
Joseph Becker	VP Communications	Profile
Sbastien Robitaille	Chief Officer	Profile
Wence Agbotounou	Chief Clinical Trial Officer	Profile
Caroline Daniere	Chief Staff	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC